Journal article
Challenging historical perspectives of the 24-h chemotherapy day: Flexible chemotherapy dose-timing guidelines
M Alexander, F Coenders, D Murray, S Kirsa, J Seymour
Asia Pacific Journal of Clinical Oncology | WILEY-BLACKWELL | Published : 2016
DOI: 10.1111/ajco.12132
Abstract
Aim: Variation in dose-timing within multiday chemotherapy regimens is largely unknown with convention being to administer subsequent days of treatment at 24-h intervals. However, in reality there are many occasions where doses are given either earlier or later to accommodate a variety of clinical and operational priorities. This project aimed to evaluate the degree of existing variation in chemotherapy dose-timing and to investigate whether deliberate variation could improve quality and efficiency outcomes such as reduction of after hours chemotherapy administration or reduced inpatient length of stay. Method: Chemotherapy charts and hospital admission datasets (n=112) from sarcoma and hema..
View full abstractGrants
Funding Acknowledgements
Peter MacCallum Cancer Centre gratefully acknowledges Roche Products, Pty Limited (Australia) for providing the funding to undertake this project. The authors would like to acknowledge the medical, pharmacy and nursing staff from the Hematology and Sarcoma units at Peter MacCallum Cancer Centre who contributed to the project steering committee and assisted with the development and implementation of the flexible dose-timing guidelines.